Startdate: 1 July 2024 - 5 July 2024
ECTS credits: 2 ECTS. For more information see credits and certificate.
Course programme
During this course you will learn about the most important aspects of the preclinical stages of modern drug discovery, some of these subject contain:
- Principles and challenges of drug discovery
- Different phases of drug discovery
- Conventional and novel therapeutic modalities
- Target identification and validation
- Assay development and hit finding through high-throughput screening
- Importance of hit triaging and validation of target engagement
- Medicinal chemistry and hit & lead optimization
- ADMET, animal PoC
- Chemistry Manufacturing and Controls
- Regulatory affairs
- IP generation and
- Clinical studies
The course will be organized jointly by Radboud University (Nijmegen), Pivot Park Life Science campus (Oss) and HAN University of Applied Sciences (Nijmegen). The content of the lectures is designed by academic and industry experts in the field of early drug discovery and the course is a combination of lectures, seminars, group assignments and visits to companies active in pharmaceutical R&D located on Pivot Park Life Science Campus.
After successful completion of this course you will understand how drugs are discovered and developed, the different phases, in general terms, of drugs discovery, the basic principles of medicinal chemistry, and the importance of factors for a molecule to become a drug.
